Changes on the palms, soles, and nails may signal this melanoma, including new pigmentation, irregular borders, nail damage, or persistent sores. Prompt evaluation matters because melanoma can resemble a bruise, wart, or injury, while prognosis depends mainly on stage and tumor thickness.
This article explains how acral lentiginous melanoma can develop in overlooked areas, what suspicious lesion patterns clinicians examine, and how diagnosis, staging, and treatment shape prognosis.
Acral Melanoma in Context
The term acral comes from the Greek word for an extremity. In skin cancer, it refers to thick skin on the palms, soles, heels, and areas around or beneath the nails. Melanoma arising in these areas has visual patterns that can escape notice during a quick inspection.
This melanoma most often affects a palm, sole, or nail unit. Although it can occur on the face, trunk, or limbs, your hands and feet require particular attention. Less visible locations and natural skin markings can delay evaluation.
Where It Can Appear
A palm or sole lesion may sit within a natural crease, making its border harder to separate from the surrounding line. On a foot, the heel and ball can conceal changes until a shoe rubs the area. Your nails present another difficulty because pigment beneath a nail can resemble bruising.
- Palm changes: A new brown, black, pink, or gray patch may cross or follow a crease.
- Sole changes: A dark spot on the heel or ball of your foot may look deceptively ordinary.
- Nail changes: A widening dark streak, persistent stain, or damaged nail plate may indicate subungual melanoma.
- Other sites: Melanoma can also arise on your face, trunk, arms, or legs.
Your history of trauma, a fresh bruise, or presumed nail damage does not eliminate the need for evaluation. The color may come from blood beneath the nail, pigment produced by cells, or both. Appearance alone cannot establish the cause, so any unexplained change deserves a closer look.
Patterns That Distinguish Suspicious Lesions
A dark spot on the heel that differs from the surrounding skin deserves attention, even without pain. Your concern should grow when a lesion enlarges, changes color, develops uneven edges, or remains unexplained. Change over time matters more than whether the spot appears dramatic.
Acral lentiginous melanoma symptoms may include brown, black, pink, gray, or several colors within one area. A lesion can become raised, crusted, cracked, or open. Bleeding without a clear injury and persistent ulceration are strong reasons to seek prompt dermatologic evaluation.
Changes That Deserve Attention
- Color variation: The area may contain tan, brown, black, pink, gray, or red tones.
- Growth: The area may enlarge over several weeks or months, even without reliable measurements.
- Uneven shape: One side may look different from the other, or the border may appear notched.
- Surface damage: Crusting, bleeding, breakdown, or an open sore may persist or return.
- Persistent change: A spot that keeps shifting in size, color, or border should not be ignored.
Itching, tenderness, burning, or pain can occur, but discomfort isn’t required. Some lesions produce few noticeable symptoms. The absence of pain offers no reliable reassurance, especially when a palm, sole, or nail changes without a clear cause.
Nail Warning Signs
A dark line beneath your nail may widen from the base toward the free edge, although not every pigmented streak follows that pattern. A nail can also split, lift, become brittle, or lose part of its normal shape. Pigment may extend onto the skin beside the nail.
For example, a thumbnail may remain discolored after a minor bump and gradually develop a darker patch. A bruise should move outward as the nail grows, but new pigment can continue appearing near the base. Your nail history and pattern of change help your clinician decide how soon to inspect it.
Why Acral Sites Challenge Routine Screening
Palm lines, pressure ridges, and thick skin can hide small changes that would stand out on your torso. A sole lesion may also be mistaken for a callus or wart, while a nail streak may be attributed to trauma. Visual inspection alone cannot resolve these mimics.
The ABCDE warning signs identify asymmetry, border irregularity, color variation, diameter, and evolution. Normal grooves, thick texture, and nail anatomy disrupt that checklist on acral skin. Your lack of an ABCDE feature does not prove that a changing lesion is harmless.
| Appearance | Possible interpretation | Reason for evaluation |
|---|---|---|
| Dark patch under a heel | Bruise or blood collection | New, expanding, or unexplained pigment needs assessment. |
| Hard spot on the sole | Callus or wart | Pain, surface change, or persistence can raise concern. |
| Dark nail line | Minor nail injury | Widening, progression, or nail destruction can be concerning. |
| Colored palm patch | Mole or post-inflammatory mark | Any unexplained change from your usual skin pattern matters. |
Risk Context
- Personal history: A previous melanoma diagnosis can increase your concern about a new or changing lesion.
- Family history: A melanoma history among close relatives may affect how carefully your clinician evaluates a suspicious area.
- Ultraviolet exposure: It contributes to melanoma risk overall, although acral melanoma can arise without a memorable sunburn history.
- Friction or trauma: Repeated injury has been studied as a possible factor, but its relationship with acral melanoma varies.
Acral lentiginous melanoma causes are not always identifiable. Your clinician may consider personal history, family history, ultraviolet exposure, and repeated friction without claiming that any single factor caused your lesion.
Those factors shape evaluation urgency, but confirming melanoma requires biopsy and, when indicated, lymph node assessment.
From Suspicious Lesion to Diagnosis
New or changing pigment on a palm, sole, or nail deserves prompt dermatologic evaluation, especially when no cause is clear. Waiting to see whether it fades may delay the tissue examination needed to settle the question. Your unexplained lesion shouldn’t become a passive observation project.
The Evaluation Sequence
- Describe the change: Note the initial discovery date, any growth, and prior injury or nail damage.
- Examine the skin or nail: A dermatologist examines the site and uses dermoscopy, which magnifies and lights the surface.
- Review risk details: The clinician considers melanoma history, family history, medicines, and your lesion’s evolution.
- Sample suspicious tissue: A small biopsy can establish whether melanoma cells are present and define the subtype.
- Map confirmed disease: Thickness and other pathology findings guide staging and decisions about lymph node evaluation.
Bring dates and photographs to your visit. A clear record of a nail streak widening or a sole spot enlarging can help the clinician judge change, even when the initial examination doesn’t settle the diagnosis.
Your diagnosis cannot be confirmed from a photograph or surface pattern alone. A skin biopsy allows a pathologist to examine the cells and determine key features. Once melanoma is confirmed, Breslow thickness measures how deeply the tumor cells extend into the skin. Ulceration, lymph node involvement, and other findings add detail.
Staging Beyond the Initial Biopsy
Your staging uses tumor features and evidence of spread to assign a stage under American Joint Committee on Cancer criteria. Sentinel lymph node biopsy may be recommended for some localized melanomas. A nearby lymph node is sampled to determine whether melanoma cells have reached it.
Imaging may help assess organs when your examination or pathology raises concern about metastasis. Scans can also guide care for advanced or recurrent disease. Your care team may combine imaging, node evaluation, and biopsy results rather than relying on one test alone.
Stage-Dependent Care Decisions
Your care plan starts with the confirmed stage, Breslow thickness, ulceration status, lymph node findings, and general health. Two lesions that look alike can lead to different decisions because laboratory findings and disease spread matter as much as surface appearance.
Localized Disease
Surgery is the main local approach for many patients with confined melanoma. Your surgeon removes the lesion with an appropriate margin of surrounding skin and nearby tissue. The margin depends on tumor thickness and other clinical factors, so appearance alone cannot determine the operative plan.
For some thicker tumors, your clinician may discuss sentinel lymph node biopsy during the same operation. Node evaluation can reveal microscopic spread and help guide later care. Thickness uncertainty calls for a melanoma-focused plan rather than a routine skin-excision plan.
Advanced or Recurrent Disease
For melanoma that has spread or returned, your specialist team may consider targeted therapy, immunotherapy, radiation, or another approach suited to your circumstances. Your options depend on the location and extent of disease, tumor features, prior care, and overall health.
Detailed guidance from the National Cancer Institute can help you understand how your stage shapes melanoma care planning. Use that information to prepare questions, not to replace a review of your own pathology and imaging results.
| Planning factor | What it contributes | Decision impact |
|---|---|---|
| Stage | Shows whether cancer remains local or appears elsewhere | Shapes the scope of your care |
| Breslow thickness | Measures tumor depth | Influences local surgery and node evaluation |
| Ulceration | Shows whether the tumor surface is broken | Adds staging detail |
| Lymph node status | Shows whether cells reached nearby nodes | Changes risk assessment and follow-up |
| Overall health | Reflects other conditions and your ability to tolerate care | Supports individualized planning |
Your complex case may involve dermatology, surgical oncology, pathology, medical oncology, and radiation oncology. A coordinated team keeps local surgery, systemic care, and surveillance connected. Your care decisions should account for disease findings rather than follow a single uniform plan.
Prognosis, Surveillance, and Next Steps
Stage and Breslow thickness remain the strongest practical influences on your melanoma outcome. Localized disease generally carries a better outlook than disease that has reached lymph nodes or distant organs. Even within the same stage, thickness can separate risk levels, so your pathology report deserves careful review.
Why Statistics Cannot Predict Your Result
Acral lentiginous melanoma prognosis figures vary across populations, age groups, stages, subtypes, and data periods. A survival rate describes a group rather than your individual future. Recurrence risk, response, and health after care depend on factors that group statistics cannot fully capture.
Some comparisons suggest that acral melanoma has a lower survival rate than another melanoma subtype. Published findings can differ because cases vary by stage at diagnosis and data source. Such comparisons can mislead without those details, particularly when acral sites are overlooked longer.
Your acral lentiginous melanoma survival rate should therefore be interpreted with your stage, thickness, ulceration, and node status. A population figure can frame the discussion, but it cannot calculate your personal outcome.
What to Monitor After Evaluation
Your surveillance plan depends on the stage, pathology, and care already received. The rest of your skin and nails also require inspection, including areas that rarely receive sun exposure. A hand or foot can develop a subtle patch, split nail, or sore that warrants an appointment.
- Check regularly: Use good lighting and compare your palms, soles, heels, fingernails, and toenails with the usual pattern.
- Photograph changes: Date images of a changing spot or nail to document its course for your clinician.
- Protect acral skin: Reduce repeated friction and avoid rubbing a new lesion against footwear.
- Report progress: Bring new pigmentation, splitting, crusting, bleeding, or nail destruction to a qualified clinician.
- Keep scheduled visits: Follow the surveillance schedule set by your melanoma care team.
A persistent unexplained dark area, worsening nail change, bleeding area, or open sore should be assessed promptly rather than watched for another several months.
Key Takeaways
Your clearest next step is prompt assessment of unexplained, new, or changing pigment on a palm, sole, or nail. Appearance alone cannot distinguish melanoma from a bruise, wart, mole, or injury. Diagnosis requires specialist examination and often a biopsy, while stage and tumor thickness carry the most weight for your outlook.
FAQ
What are the early symptoms of acral lentiginous melanoma?
The first signs may include a new brown, black, pink, gray, or multicolored area that differs from your normal skin or nail pattern. Growth, irregular borders, crusting, bleeding, dark nail streaks, or nail splitting can signal concern. Some lesions cause no pain or other noticeable symptom.
What is acral lentiginous melanoma?
This melanoma subtype usually develops on acral skin, including a palm, sole, heel, or nail unit. Your clinician confirms the diagnosis through examination and tissue testing rather than appearance alone.
Where does acral lentiginous melanoma most often develop?
It most often appears on a palm, sole, heel, or beneath a fingernail or toenail. Melanoma can also develop elsewhere, including your face, trunk, and limbs. Natural creases and less visible locations can delay recognition.
Where does acral lentiginous melanoma usually appear?
It usually appears on a palm, sole, heel, or nail unit. Your palms, soles, and nails can develop lesions that resemble bruises, stains, or ordinary skin markings, so progressive changes deserve evaluation.
What are the early symptoms and warning signs?
New or multicolored pigmentation, growth, irregular borders, crusting, bleeding, persistent ulcers, and nail splitting can appear early. A widening streak beneath a nail may indicate subungual melanoma. Your lesion may cause no pain.
How does melanoma on the palm, sole, or nail look different from a benign mole?
A suspicious palm or sole lesion may differ in color, border, shape, or size from your usual pattern. A nail streak may widen, persist, or extend onto adjacent skin. A benign mole generally remains stable, although appearance alone cannot establish the diagnosis.
